Specifically, GPT acts as a protective factor affecting the prognosis of ACC (HR: 0.373), BRCA (HR: 0.832), KIRC (HR: 0.869), KIRP (HR: 0.720), LGG (HR: 0.739), LIHC (HR: 0.840) and acts as a risk factor affecting the prognosis of THYM (HR: 2.495) (Figure 11A). This evidence concerns the gene GPT and adrenal cortex carcinoma.